Application of Section 101 in Life Sciences Patents: Leveraging Revised USPTO Guidelines, Recent Decisions
Implications for Patent Prosecution, Litigation and Reform
Recording of a 90-minute premium CLE webinar with Q&A
The CLE webinar will guide patent counsel on patent eligibility in life sciences patents, examining the latest Federal Circuit decisions, Patent Trial and Appeal Board cases, and U.S. Patent and Trademark Office (USPTO) guidance. The panel will offer best practices for navigating the interplay between the Federal Circuit and the USPTO and addressing life sciences patent eligibility issues.
- Recent life sciences decisions
- Practical applications: prosecution guidance
- Practical applications: litigation and diligence guidance
- Legislative updates
The panel will review these and other relevant issues:
- How are the courts applying the framework for patent eligibility created in Alice in life sciences cases?
- How can patent counsel meet the requirements under Section 101 in patent applications for life sciences inventions?
- What steps should patent counsel take to minimize the likelihood of 101 rejections with life sciences patent applications?
Amelia Feulner Baur, Ph.D
Dr. Baur’s practice covers a broad spectrum of intellectual property issues, including patent preparation and... | Read More
Dr. Baur’s practice covers a broad spectrum of intellectual property issues, including patent preparation and prosecution, coordination of worldwide patent strategies, appeals to the Patent Trial and Appeal Board and the Court of Appeals for the Federal Circuit. She has extensive experience working with clients to develop effective patent strategies to meet business goals. This includes landscape analyses, due diligence investigations, and providing patentability, freedom-to-operate, infringement, and validity opinions. She has also led clients through inter partes review (IPR), reexaminations, interferences, and the settlement of patent disputes.Close
Nicole A. Conlon, Ph.D.
Dr. Conlon assists clients with pre-litigation strategy, due diligence investigations, contentious patent office... | Read More
Dr. Conlon assists clients with pre-litigation strategy, due diligence investigations, contentious patent office proceedings, freedom-to-operate analyses, and prosecution portfolio management. She has defended and challenged pharmaceutical patents and has represented innovator companies in high-stakes district court actions, often involving parallel IPR proceedings. Her trial experience includes biologics cases, arbitrations, and Hatch-Waxman litigation. She offers expertise in monoclonal antibodies, gene editing and recombinant nucleic acid technologies, vaccine products, and immunological therapies.Close
Supervisory Patent Examiner
Mr. Kolker oversees art unit 1644, which examines applications in immunology. He works closely with junior examiners in... | Read More
Mr. Kolker oversees art unit 1644, which examines applications in immunology. He works closely with junior examiners in the art unit, and is an expert on patent subject matter eligibility, particularly in the biotechnology area. He received a Ph.D. in neuroscience. He was an examiner in TC1600, where he examined patent applications in the fields of neurobiology, receptors, and cytokines before becoming a supervisory patent examiner.Close